Abstract
To the Editor: The impact of pregnancy on cutaneous T-cell lymphoma (CTCL) and lymphoproliferative disorders (LPDs) is largely unexplored territory, limited to case reports and series with conflicting results.1-4 In clinical practice, this uncertainty is often averted as most female patients are diagnosed after childbearing years. Nevertheless, for patients considering pregnancy, the lack of available data and limited pregnancy-safe treatment options can be distressing.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
